Skip to content
Back to Insights

Strategy

Why PE-Backed Companies Approach Growth Backwards

March 2026 · 6 min read

Zachary Nippert

Zachary Nippert

Founder, Managing Partner

Walk into almost any PE-backed portfolio company mid-hold and ask the leadership team what their top commercial priority is. Nine times out of ten, the answer is some version of the same thing: we need to grow the top line, so we're focused on new customer acquisition.

It sounds reasonable. It's what growth is supposed to look like. And it's almost always the wrong place to start.

The acquisition-first reflex

The bias toward new logos is deeply embedded in how most commercial teams are built and incentivized. Sales comp plans reward new bookings. Marketing budgets flow toward demand generation. The board wants to see pipeline. So that's where the energy goes.

The problem is that new customer acquisition is the slowest, most expensive, and highest-failure-rate commercial motion available to you. CAC is high. Sales cycles are long. Win rates at most mid-market B2B companies hover between 20–30%. And every dollar spent chasing a new logo is a dollar not spent on the existing customers who are already paying you, already know you, and are already deciding whether to stay.

1 in 3 commercial growth initiatives fail to deliver results, and the failure rate is highest for acquisition-led programs. (Simon-Kucher)

What's leaking while you're hunting

Most mid-market portfolio companies are losing 15–25% of revenue annually to churn, pricing leakage, and expansion they never captured. That's not a pipeline problem. That's a retention and monetization problem, and it's invisible on most dashboards because the metrics aren't being tracked at the right level of granularity.

Pricing leakage is particularly insidious. It shows up as contract variability, different customers paying wildly different rates for the same product or service, often with no logical basis. It shows up as discounting behavior that's become normalized. It shows up as packaging that hasn't been updated since the company was a third of its current size. None of it appears as a line item. It just quietly compresses margin.

Churn is more visible but often misdiagnosed. The at-risk accounts, the ones who've gone quiet, reduced usage, or started asking pointed questions about contract renewal, are almost always identifiable in advance. The problem is that most teams aren't looking systematically until the cancellation notice arrives.

The sequence that actually works

The R.E.A.L. framework sequences commercial work by speed-to-impact and certainty of return. It's not a philosophy. It's a prioritization system built from what actually moves the needle in PE-hold timelines.

  • Retain first. Stop the bleeding before you try to grow. Fix the pricing architecture, intervene on at-risk accounts, and get churn to a level that doesn't undermine everything else you're building. This is the fastest path to demonstrable EBITDA impact, and it builds the credibility with the board to fund the rest of the transformation.

  • Expand second. Your existing customers are the most efficient growth surface you have. They already trust you. Sales cycles are shorter, win rates are higher, and the CAC is a fraction of what you'd spend acquiring a new logo. Cross-sell, upsell, pricing optimization, wallet share expansion: this is where most companies leave the most money on the table.

  • Align third. Fix the commercial engine before you try to scale it. Sales process, GTM architecture, marketing-sales alignment, team structure and comp. If you try to pour acquisition budget into a broken engine, you don't get more growth, you get more expensive failure.

  • Land last. Once you've stopped the bleeding, monetized what you have, and built an engine worth scaling, then go acquire. Now your CAC is defensible, your retention economics support the investment, and your sales motion is repeatable enough to actually scale.

Why the sequence matters to exit

This isn't just about operational efficiency. It's about what buyers pay for. Organic growers command 50% higher exit multiples than companies with equivalent revenue built primarily through acquisition, according to Gain.pro's analysis of 10,000+ deals. Buyers are paying for the quality and durability of the revenue, not just the size of it.

A company with 90% gross retention, expanding NRR, and a demand gen engine running on 80%+ margins tells a completely different exit story than a company with equivalent topline built on churn-and-churn, heavy discounting, and a CAC ratio that only makes sense if you squint.

A $3M EBITDA improvement is worth $30M at exit at a 10x multiple. The question is which path to that $3M is fastest, most certain, and most defensible in diligence.

Starting with retention isn't conservative. It's the highest-certainty, fastest-payback path to EBITDA that also builds the foundation for everything that follows. The companies that get this right don't just have better exits, they have better stories to tell.

Ready to put this into practice?

Start a diagnostic